Early ADHD diagnosis is associated with improved educational outcomes, whereas late diagnosis increases the risk of school dropout.

Among people with major depressive disorder, treatment with semaglutide reduces the perceived cost of effort and improves motivation.

Significant genetic correlations were found between pediatric neuropsychiatric conditions and various ocular disorders.

An analysis of more than 500 nonprofit hospitals in the US has found no evidence that hiring management consultants leads to “meaningful changes” to finances, operations, or patient quality of care, ...

New AAP guidance emphasizes longitudinal assessment and collaborative partnerships to foster healthy mental and emotional development in children.

Treatments for COVID-19, gout, nicotine dependence, severe hypertriglyceridemia, and thyroid eye disease are under review.

Most people that are admitted to the hospital for psychiatric needs are eventually readmitted or engage with hospital-based psychiatry again.

Among Medicare beneficiaries there was a decline in primary care visits, and limited telemedicine use between 2017 and 2023.

LB-102 vs placebo significantly improved PANSS total scores in adults with acute exacerbation of schizophrenia.

Based on data from 2024, an estimated 8 million people in the US have used psilocybin for various purposes in the last year.

The FDA approved expanded use of Auvelity, an extended release major depressive disorder drug, for use in the treatment of Alzheimer disease.

Sustained methylphenidate treatment was not linked to nonaffective psychosis in children and adolescents with ADHD.